Receptor-misrouting: An unexpectedly prevalent and rescuable etiology in GnRHR-mediated hypogonadotropic hypogonadism

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 10, 2002, Pages 4825-4828

  Leaños Miranda, Alfredo ^a   Janovick, Jo Ann ^a   Michael Conn, P ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [5 [2 (AZABICYCLO[2.2.2]OCT 2 YL) 1,1 DIMETHYL 2 OXOETHYL] 2 (3,5 DIMETHYLPHENYL) 1H INDOL 3 YL] N (2 PYRIDIN 4 YLETHYL)PROPAN 1 AMINE; BACTERIAL ANTIGEN; GONADORELIN ANTAGONIST; GONADORELIN RECEPTOR; GREEN FLUORESCENT PROTEIN; IN 3; INOSITOL PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HYPOGONADOTROPIC HYPOGONADISM; LIGAND BINDING; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN STABILITY; RECEPTOR BINDING;

ANIMALS; BIOLOGICAL TRANSPORT; BUSERELIN; COS CELLS; HYPOGONADISM; INOSITOL PHOSPHATES; MUTATION; MUTATION, MISSENSE; PROTEIN FOLDING; RECEPTORS, LHRH; TRANSFECTION;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0036774528     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020961     Document Type: Article

References (27)

1. Seminara SB, Hayes FJ, Crowley Jr. WF 1998 Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallman's syndrome): Pathophysiological and genetic considerations. Endocr Rev 19: 521 - 539
2. de Roux N, Young J, Misrahi M. Genet R, Chanson P. Schaison G, Milgrom E 1997 A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med 337: 1597 - 1602
3. Layman LC, Cohen DP, Jin M, Xie J, Li Z, Reindollar RH, Bolbolan S 1998 Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nature Genetics 18: 14 - 15
4. Caron P, Chauvin S, Christin-Maitre S, Bennet A, Lahlou N, Counis R, Bouchard, P, Kottler, M-L 1999 Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. J Clin Endocrinol Metab 84: 990 - 996
5. de Roux N, Young J, Brailly-Tabard S, Misrhai M, Milgrom E, Schaison G 1999 The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred. J Clin Endocrinol Metab 84: 567 - 572
6. Kottler M-L, Chauvin S, Lahlou N, Harris CE, Johnston CJ, Lagarde JP. Bouchard P, Farid N, Counis R 2000 A new compound heterozygous mutation of the gonadotropin-releasing hormone receptor (L314X, QI06R) in a woman with complete hypogonadotropic hypogonadism: chronic estrogen administration amplifies the gonadotropin defect. J Clin Endocrinol Metab 85: 3002 - 3008
7. Beranova M, Oliveira LMB, Bédécarrats GY, Schipani E, Vallejo M, Ammini AC, Quintos JB, Hall JE, Martin KA, Hayes FJ, Pitteloud N, Kaiser UB, Crowley Jr. WF, Seminara SB 2001 Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 86: 1580 - 1588
8. Pralong FP, Gomez F, Castillo E, Cotecchia S, Abuin L, Aubert ML, Portmann L 1999 Complete hypogonadotropic associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor J Clin Endocrinol Metab 84: 3811 - 3816
9. Soderlund D, Canto P, de la Chesnaye E, Ulloa-Aguirre A, Méndez JP 2001 A novel homozygous mutation in the second transmembrane domain of gonadotropin-releasing hormone receptor gene. Clin Endocrinol (Oxf) 54: 493 - 498
10. Costa EMF, Bedecarrats GY, Mendonca BB, Arnhold IJP, Kaiser UB, Latronico AC 2001 Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction. J Clin Endocrinol Metab 86: 2680 - 2686
11. Pitteloud N, Boepple PA, DeCruz S, Valkenburgh SB, Crowley Jr. WF, Hayes FJ. 2001 The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: Spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor. J Clin Endocrinol Metab 86: 2470 - 2475
12. Ashton WT, Sisco RM, Yang YT, Lo J-L, Yudkovich JB, Cheng K, Goulet, MT 2001 Substituted indole-5-carboxamides and - acetamides as potent nonpeptide GnRHR receptor antagonists. Bioorg Med Chem Lett 11: 1723 - 1726
13. Ashton WT, Sisco RM, Yang YT, Lo J-L, Yudkovich JB, Gibbons PH, Mount GR, Ren RN, Butler BS, Cheng K, Goulet MT 2001 Potent nonpeptide GnRHR receptor antagonists derived from indole-5-carboxamides and -acetamides bearing a pyridine side-chain terminus. Bioorg Med Chem Lett 11: 1727 - 1731
14. Ashton WT, Sisco RM, Kieczykowsky GR, Yang YT, Yudkovich JB, Cui J, Mount GR, Ren RN. Woo T-J, Shen X, Lyons KA, Mao A-H, Carlin JR, Karanam BV, Vincent SH, Cheng K, Goulet MT 2001 Orally bioavailable, indole-based nonpeptide GnRHR receptor with high potency and functional activity. Bioorg Med Chem Lett 11: 2597 - 2602
15. Janovick JA, Maya-Nunez G. Conn PM 2002 Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: Misrouted protein as a novel disease etiology and therapeutic target. J Clin Endocrinol Metab 87: 3255 - 3262.
16. Soto C 2001 Protein misfolding and disease; protein refolding and therapy. FEBS Lett 498: 204 - 207
17. Morello J-P, Salahpour A, Laperriere A, Bernier V, Arthus M-F. Lonergan M, Petäjä-Repo U, Angers S, Morin D, Bichet DJ, Bouvier M 2000 Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 105: 887 - 895
18. Colley NJ, Cassil JA, Baker EK, Zuker CS 1995 Defective intracellular transport is the molecular basis of rhodopsin-dependent dominant retinal degeneration. Proc Natl Acad Sci USA 92: 3070 -3074
19. Hammond C, Helenius A 1995 Quality control in the secretory pathway. Curr Opin Cell Biol 7: 523 - 529
20. Welch WJ, Howard M 2000 Antagonists to the rescue. J I Clin Invest 105: 853 - 854
21. Maya-Nuñez G, Janovick J, Conn PM. 2000 Combined modification of intracellular and extracellular loci on human gonadotropin-releasing hormone receptor provides a mechanism for enhanced expression. Endocrine 13: 401 - 409
22. 90K) GnRH receptor function by deletion at a distant site. J Clin Endocrinol Metab 87: 2144 - 2149
23. Shubert U, Antón LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR. 2000 Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404: 770 - 774
24. Petäjä-Repo UE, Hogue M, Laperriere A, Walker P, Bouvier M. 2000 Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human δ opioid receptor. J Biol Chem 275: 13727 - 13736
25. Petäjä Repo UE, Hogue M, Laperriere A, Bhalla S, Walker P, Bouvier M 2001 Newly synthesized human δ 5 opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated ubiquitinated, and degraded by the proteasome. J Biol Chem 276: 4416 - 4423
26. Petäjä-Repo UE, Hogue M, Bhalla S, Laperriere A,. Morello J-P. Bouvier M 2002 Ligands act as pharmacological chaperones and increase the efficiency of δ opioid receptor maturation. EMBO J 21: 1618 - 1637
27. Edwards SW, Tan CH, Limbird LE 2000 Localization of G-protein-coupled receptors in health and disease. Trends Pharmacol Sci 21: 304 - 308